EXTRACORPÓREA PHOTOPHERESIS IN COMBINATION WITH ANTI-TNF TREATMENT.

摘要

A combined product comprising: a) a population of ex vivo cells that has undergone an ex vivo apoptosis induction treatment; and b) infliximab in a dose not exceeding 3 mg / kg, c) for combined, simultaneous or sequential administration to a patient for use in treating an autoimmune disease or in improving one or more symptoms thereof.